Package 0173-0898-03

Brand: jemperli

Generic: dostarlimab
NDC Package

Package Facts

Identity

Package NDC 0173-0898-03
Digits Only 0173089803
Product NDC 0173-0898
Description

1 VIAL in 1 CARTON (0173-0898-03) / 10 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2021-04-22
Brand jemperli
Generic dostarlimab
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "ecb4fc05-fc32-4952-a128-fbd459b050e2", "openfda": {"nui": ["N0000191260", "N0000191259"], "unii": ["P0GVQ9A4S5"], "rxcui": ["2539972", "2539977"], "spl_set_id": ["095eab9f-545a-4f12-bfb7-19477fb901a5"], "pharm_class_epc": ["Programmed Death Receptor-1 Blocking Antibody [EPC]"], "pharm_class_moa": ["Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0173-0898-03)  / 10 mL in 1 VIAL", "package_ndc": "0173-0898-03", "marketing_start_date": "20210422"}], "brand_name": "Jemperli", "product_id": "0173-0898_ecb4fc05-fc32-4952-a128-fbd459b050e2", "dosage_form": "INJECTION", "pharm_class": ["Programmed Death Receptor-1 Blocking Antibody [EPC]", "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "product_ndc": "0173-0898", "generic_name": "dostarlimab", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Jemperli", "active_ingredients": [{"name": "DOSTARLIMAB", "strength": "50 mg/mL"}], "application_number": "BLA761174", "marketing_category": "BLA", "marketing_start_date": "20210422", "listing_expiration_date": "20261231"}